Rhythmia Medical

Arrhythmia device firm Rhythmia Medical raises $5 million

Rhythmia Medical Inc. drummed up $5 million in equity from eight investors, according to a Securities & Exchange Commission filing. The Burlington, Mass.-based developer of medical devices for treating arrhythmia is still $2 million shy of its $7 million target for this funding round, according to the filing. The identity of the participants in the […]

By MassDevice Staff

News

ATS Medical CEO tapped for Rhythmia Medical board

Rhythmia is developing a device used to treat heart arrhythmia or abnormal beating, a condition that can lead to heart disease and stroke.

By Thomas Lee

With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?

Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.